142 related articles for article (PubMed ID: 8453625)
21. [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma].
Fischel JL; Barbé V; Berlion M; Formento P; Berrile J; Bizzari JP; Milano G
Bull Cancer; 1994 Jul; 81(7):599-604. PubMed ID: 7742602
[TBL] [Abstract][Full Text] [Related]
22. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Nukatsuka M; Nagase H; Nomura T; Hirono M; Yamamoto Y; Sugimoto Y; Oka T; Sonoo H
Cancer Chemother Pharmacol; 2007 Mar; 59(4):515-25. PubMed ID: 16900372
[TBL] [Abstract][Full Text] [Related]
23. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
[TBL] [Abstract][Full Text] [Related]
24. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen enhances apoptotic effect of cisplatin on primary endometrial cell cultures.
Drucker L; Stackievicz R; Radnay J; Shapira H; Cohen I; Yarkoni S
Anticancer Res; 2003; 23(2B):1549-54. PubMed ID: 12820422
[TBL] [Abstract][Full Text] [Related]
26. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
27. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
32. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
33. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
34. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
Jekunen A; Vick J; Sanga R; Chan TC; Howell SB
Cancer Res; 1992 Jul; 52(13):3566-71. PubMed ID: 1617625
[TBL] [Abstract][Full Text] [Related]
35. [Hormone-dependency of human breast cancer in in vitro clonogenic assay].
Nomura Y; Tashiro H; Takaekoh F; Hisamatsu K
Gan No Rinsho; 1987 Feb; 33(2):153-8. PubMed ID: 3560449
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
Mikhaevich IS; Vlasenkova NK; Gerasimova GK
Biomed Sci; 1991; 2(6):659-64. PubMed ID: 1841636
[TBL] [Abstract][Full Text] [Related]
37. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
Melvik JE; Pettersen EO
Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma.
Zaffaroni N; Villa R; Daidone MG; Vaglini M; Santinami M; Silvestrini R
Int J Cell Cloning; 1989 Nov; 7(6):385-94. PubMed ID: 2809274
[TBL] [Abstract][Full Text] [Related]
39. A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma.
McClay EF; McClay ME; Jones JA; Winski PJ; Christen RD; Howell SB; Hall PD
Cancer; 1997 Mar; 79(5):1037-43. PubMed ID: 9041168
[TBL] [Abstract][Full Text] [Related]
40. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
Jekunen AP; Christen RD; Shalinsky DR; Howell SB
Br J Cancer; 1994 Feb; 69(2):299-306. PubMed ID: 7905279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
